Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2008
07/09/2008EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
07/09/2008CN101218237A Oxime derivative and preparations thereof
07/09/2008CN101218211A Quinoxaline derivatives as antitumor agents
07/09/2008CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases
07/09/2008CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
07/09/2008CN101215236A Beta-disubstituted chiral aldehydes, synthesis method and use thereof
07/09/2008CN100400537C Red fluorescent dye compound. preparation process and application thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/09/2008CN100400518C Phthalazinone derivatives
07/09/2008CN100400513C Phenylalanine enamide derivatives
07/08/2008US7396936 Modulators of calcitonin and amylin receptor activity
07/08/2008US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
07/08/2008US7396851 Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia
07/08/2008US7396840 Chemokine receptor binding heterocyclic compounds
07/08/2008US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
07/08/2008US7396836 Pyrimidine compound and medicinal composition thereof
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008US7396828 PI-3 kinase inhibitor prodrugs
07/08/2008CA2432131C Pyrazole compounds useful as protein kinase inhibitors
07/08/2008CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists
07/08/2008CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
07/08/2008CA2200324C 4a-aryldecahydroisoquinoline compounds and medicinal use of the same
07/08/2008CA2092868C Process for producing 4-substituted azetidinone derivatives
07/03/2008WO2008080120A2 3-amino chromane derivatives
07/03/2008WO2008080056A2 Pyridazinones and furan-containing compounds
07/03/2008WO2008079787A2 Glucokinase activators
07/03/2008WO2008079316A1 Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof
07/03/2008WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
07/03/2008WO2008079028A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008WO2008077724A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them
07/03/2008WO2008077548A1 Pyrimidyl derivatives as protein kinase inhibitors
07/03/2008WO2008049919A3 Rho kinase inhibitors
07/03/2008WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles
07/03/2008WO2008019030A3 Modified azole compounds as antiinfective agents
07/03/2008WO2008006499A3 Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones
07/03/2008WO2008005955A8 Synthesis of heterocyclic compounds
07/03/2008WO2007137066A3 HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
07/03/2008WO2007107276A3 Process for preparing c7 intermediates and their use in the preparation of n-substituted pyrrole derivatives
07/03/2008US20080161374 Pyrazole compounds and uses related thereto
07/03/2008US20080161345 Aryl Sulfonamides
07/03/2008US20080161323 Piperazine Derivatives of Alkyl Oxindoles
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161287 Bicyclic compound, production and use thereof
07/03/2008US20080161285 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
07/03/2008CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure
07/03/2008CA2674525A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors
07/03/2008CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors
07/03/2008CA2673299A1 Pyridazinones compounds for the treatment of proliferative diseases
07/03/2008CA2672718A1 Pyrimidyl derivatives as protein kinase inhibitors
07/02/2008WO2007087518A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/02/2008EP1939625A2 Methods for ligand discovery
07/02/2008EP1939192A1 Cyclopentanone derivatives, method of synthesis and uses thereof
07/02/2008EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use
07/02/2008EP1937670A1 Benzimidazolones which have activity at m1 receptor
07/02/2008EP1937669A1 Novel benzopyran derivatives as potassium channel openers
07/02/2008EP1937649A1 Imidazole derivatives for the treatment of anxiety and related diseases
07/02/2008EP1937643A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
07/02/2008EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
07/02/2008EP1937636A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl¨azetidin-2-one
07/02/2008EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators
07/02/2008EP1501808B1 Tachykinin receptor antagonists
07/02/2008EP1333828B1 Prevention of development of dyskinesias
07/02/2008CN101213194A Indazoles useful in treating cardiovascular diseases
07/02/2008CN101213193A Mono-lysine salts of azole compounds
07/02/2008CN101213188A Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation
07/02/2008CN101213187A Isoquinoline derivatives as inhibitors of RHO-kinase
07/02/2008CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
07/02/2008CN101213183A Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
07/02/2008CN101213174A Oxindole compounds and their uses as therapeutic agents
07/02/2008CN101213170A Process for production of 4-biphenylylazetidin-2-ones
07/02/2008CN101212973A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101212972A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
07/02/2008CN101210012A Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof
07/02/2008CN101210011A Quinolines compounds and their intermediates, preparation method and application
07/02/2008CN101209995A 5-amidopyrazole derivatives, preparation method and use thereof
07/02/2008CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5
07/02/2008CN100398534C New method of synthesizing thalidomide and its derivative
07/02/2008CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
07/02/2008CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/01/2008US7393873 Arylsulfonamide derivatives
07/01/2008US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
07/01/2008US7393861 Derivatives of 4-aminopiperidine and their use as a medicament
07/01/2008US7393858 Tetrahydropyran compounds as tachykinin antagonists
07/01/2008US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects
07/01/2008US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis
07/01/2008US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease
07/01/2008US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis
06/2008
06/26/2008WO2008076862A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
06/26/2008WO2008076336A2 Imidazoles as aldosterone synthase inhibitors
06/26/2008WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
06/26/2008WO2008076046A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
06/26/2008WO2008076044A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
06/26/2008WO2008076043A1 Novel 2-amino-5,5-diaryl-imidazol-4-ones
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008075064A1 Piperidine derivatives for the treatment of obesity
06/26/2008WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
06/26/2008WO2008074832A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
06/26/2008WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors